- Research works
- 65 ▲ 67% vs 2013–17
- Citations
- 1.8k 27.4 per fractional work
- Top-10% rate
- 27.5% record average 16.5%
- Open access
- 40% world 28%
Not ranked overall: BioInvent (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at BioInvent (Sweden)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer, Autoimmunity and Immune System.
- Oxidized LDL
- Cytokines
- Therapeutic Targets
- Protein Microarrays
- Tumor Regression
- Lymphoma
- Stability
- Immune Response
- Biopharmaceuticals
- Vaccine Adjuvants
- Natural Killer Cells
- Antigen Presentation
- Immunity
- Dendritic Cells
- TGF-ß
- Mucins
- Immune System
- Cancer
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Autoimmunity
- Glycans
- Foxp3
- Inflammation
- Cancer Immunotherapy
- Innate Immunity
- NK Cell Recognition
- Tumor Antigen
- Immunotherapy
- Recombinant Proteins
- Protein Aggregation
- Atherosclerosis
- Rituximab
- High-Throughput Analysis
- Regulatory T Cells
- Adaptive Immunity
- Leukemia
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation18▲ 129×3 topics
- Monoclonal Antibodies14▲ 150×2 topics
- Therapeutic Antibodies14▲ 167×2 topics
- Antibody Engineering12▲ 181×1 topic
- Fc Receptors12▲ 181×1 topic
- Cancer8▲ 8.6×14 topics
- Autoimmunity6▲ 46×4 topics
- Immune System6▲ 28×2 topics
- Glycans6▲ 110×1 topic
- Mucins6▲ 110×1 topic
- Foxp35▲ 105×1 topic
- TGF-ß5▲ 46×1 topic
- Inflammation5▲ 3.2×19 topics
- Dendritic Cells5▲ 62×2 topics
- Cancer Immunotherapy4▲ 49×2 topics
- Immunity4▲ 16×6 topics
- Innate Immunity3▲ 14×2 topics
- Antigen Presentation3▲ 48×2 topics
- NK Cell Recognition3▲ 45×1 topic
- Natural Killer Cells3▲ 45×1 topic
- Tumor Antigen3▲ 57×1 topic
- Vaccine Adjuvants3▲ 57×1 topic
- Immunotherapy2▲ 6.0×6 topics
- Biopharmaceuticals2▲ 55×2 topics
- Recombinant Proteins2▲ 70×2 topics
- Immune Response2▲ 5.8×8 topics
- Protein Aggregation2▲ 44×1 topic
- Stability2▲ 18×1 topic
- Atherosclerosis2▲ 9.2×4 topics
- Lymphoma2▲ 23×3 topics
- Rituximab2▲ 21×3 topics
- Tumor Regression2▲ 36×2 topics
- High-Throughput Analysis2▲ 68×1 topic
- Protein Microarrays2▲ 156×1 topic
- Regulatory T Cells2▲ 25×2 topics
- Therapeutic Targets2▲ 11×3 topics
- Adaptive Immunity2▲ 97×1 topic
- Cytokines2▲ 9.7×2 topics
- Leukemia2▲ 41×2 topics
- Oxidized LDL2▲ 97×1 topic
Which research topics does BioInvent (Sweden) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, CAR-T cell therapy research and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 2 Immunotherapy and Immune Responses Immunology 1 works
- 3 CAR-T cell therapy research Oncology 0 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 5 HER2/EGFR in Cancer Research Oncology 0 works
- 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
- 7 T-cell and B-cell Immunology Immunology 0 works
- 8 Virus-based gene therapy research Genetics 0 works
- 9 Cancer Research and Treatments Biotechnology 0 works
- 10 Immune Cell Function and Interaction Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has BioInvent (Sweden)'s research output changed?
Output in 2018–2022 was 67% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lund
- Lund University
- Skåne University Hospital
- MAX IV Laboratory
- European Spallation Source
- Lund Science (Sweden)
- Informa (Sweden)
- Swedish Institute for Health Economics
- Ideon Science Park
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.